To see the other types of publications on this topic, follow the link: HIV/Hepatitis C.

Books on the topic 'HIV/Hepatitis C'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 books for your research on the topic 'HIV/Hepatitis C.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Ireland. Hepatitis C Compensation Tribunal. Annual report of the Hepatitis C Compensation Tribunal. Stationery Office, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Saskatchewan Subcommittee on HIV/AIDS. Guidelines for the management of potential exposures to Hepatitis B, Hepatitis C, HIV, and recommendations for post-exposure prophyalxis. Saskatchewan Health, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Dublin, Ireland. Minister for Justice, Equality, and Law Reform. and Trinity College (Dublin, Ireland). Dept. of Community Health and General Practice., eds. Hepatitis B, hepatitis C and HIV in Irish prisoners: Prevalence and risk. Stationery Office, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Musharraf, Husain, and Population Council (Bangladesh), eds. Prevalence of HIV, HBV, HCV and syphilis markers in pregnant women of Bangladesh. Population Council, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

San Francisco (Calif.). Dept. of Public Health. Communicable Disease Control Unit. Registry match: Chronic hepatitis B, hepatitis C infection and HIV : 2010, San Francisco, California. San Francisco Department of Public Health, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Association, American Nurses. HIV, Hepatitis-B, Hepatitis-C: Blood-borne diseases; nurses' risks, rights, and responsibilities. ANA, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Dias, Giselle. Hard time: HIV and hepatitis C prevention programming for prisoners in Canada. Canadian HIV/AIDS Legal Network = Râeseau juridique canadien VIH/Sida, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Thiemann, Lillian. Double jeopardy: The HIV/HCV co-infection handbook. Community Prescription Service, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Ruiz, Juan D. Seroprevalence of HIV, hepatitis B, hepatitis C, and risk behaviors among inmates entering the California correctional system. California Dept. of Health Services, Office of Aids, HIV/AIDS Epidemiology Branch, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Tribunal of Inquiry into the Infection with HIV and Hepatitis C of Persons with Haemophilia and Related Matters. Report of the Tribunal of Inquiry into the Infection with HIV and Hepatitis C of Persons with Haemophilia and Related Matters. Stationery Office, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
11

Trinity, College (Dublin Ireland) Dept of Community Health and General Practice. Hepatitis B, hepatitis C, and HIV in Irish prisoners, part II: Prevalence and risk in committal prisoners 1999 : report prepared for the Minister for Justice, Equality, and Law Reform. Stationary Office?, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
12

Jürgens, Ralf. HIV/AIDS and HCV in prisons: A select annotated bibliography. International Affairs Directorate, Health Canada, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
13

Association, Canadian Hospital, ed. Guide to policies for health care facilities and agencies: Bloodborne pathogens, especially Human Immunodeficiency Virus (HIV), Hepatitis B Virus, (HBV) and Hepatitis C Virus (HCV). Canadian Hospital Association, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
14

Cook, Catherine. The global state of harm reduction 2008: Mapping the response to drug-related HIV and hepatitis C epidemics. International Harm Reduction Association, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
15

Swan, Tracy. Care and treatment for hepatitis C and HIV coinfection: Expanding access through the Ryan White CARE Act. U.S. Department of Health and Human Services, Health Resources and Services Administration, HIV/AIDS Bureau, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
16

Health, New York (State) Legislature Assembly Committee on. Public hearing, health care in New York State prisons. EN-DE Reporting, Inc., 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
17

New York (State). Legislature. Assembly. Committee on Health. Public hearing, health care in New York State prisons. Associated Reporters Int'l., 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
18

Duncan, Tim. Conquering Hepatitis C and surviving treatment: An essential guide through every step of the HCV treatment process. T. Duncan, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
19

Network, Canadian Harm Reduction. Learning from each other: Enhancing community-based harm reduction programs and practices in Canada. Canadian AIDS Society, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
20

Kiwamu, Okita, ed. HCV/oxidative stress and liver disease. Springer, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
21

Dammacco, Franco. HCV Infection and Cryoglobulinemia. Springer-Verlag Italia, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
22

Giulio, Pisani, ed. Nucleic acid amplification technology (NAT) for the detection of Hepatitis C Virus (HCV) in plasma pools: Validation report. Istituto superiore di sanità, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
23

Mohamed Hatem Fathi El-Saied Wali. Natural history, factors affecting severity and progression rate of hepatitis c virus (HCV) infection in liver transplanted and non-transplanted patients. University of Birmingham, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
24

Price, Jennifer Cohen, Priyanka Amin, and Antoine Douaihy. Hepatitis C and HIV Co-Infection. Edited by Mary Ann Cohen, Jack M. Gorman, Jeffrey M. Jacobson, Paul Volberding, and Scott Letendre. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199392742.003.0043.

Full text
Abstract:
Chronic infection with hepatitis C virus (HCV) is a leading cause of end-stage liver disease and is the most common indication for liver transplantation in the United States. Because of shared risk factors, individuals living with HIV infection are disproportionately affected by HCV. Moreover, co-infection with HIV accelerates the natural history of chronic HCV infection, increasing the risk of cirrhosis, hepatocellular carcinoma, hepatic decompensation, and death. Highly effective medications such as direct-acting antivirals (DAA) to cure HCV are now available and have the potential to profou
APA, Harvard, Vancouver, ISO, and other styles
25

HIV, STIs, HEPATITIS B (HBV) and HEPATITIS C (HCV) ISSUES for MEDICARE LOCALS. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
26

The national policy guidelines on post exposure prophylaxis for HIV, hepatitis B and hepatitis C. Ministry of Health, 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
27

Northcott, Herbert C. HIV/hepatitis C issues in Alberta: The 2000 survey of adults. Alberta health and Wellness, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
28

McBride, Andrew, Karin Arnold, and Richard Pates. Injecting Illicit Drugs. Wiley & Sons, Incorporated, John, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
29

McBride, Andrew, Karin Arnold, and Richard Pates. Injecting Illicit Drugs. Wiley & Sons, Incorporated, John, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
30

McBride, Andrew, Karin Arnold, and Richard Pates. Injecting Illicit Drugs. Wiley & Sons, Limited, John, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
31

Lions, Rick. Call for Action, A: HIV/AIDS and Hepatitis C in Irish Prisons. Irish Penal Reform Trust, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
32

Schramm, Wolfgang, and Inge Scharrer. 25. Hämophilie-Symposium Hamburg 1994 : Verhandlungsberichte : HIV-Infektion Pädiatrische Hämostaseologie Synovitis Thrombophilie: APC-Cofaktor Hepatitis C. Springer London, Limited, 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
33

Schramm, Inge Scharrer Wolfgang. 25. Hämophilie-Symposion Hamburg 1994 : Verhandlungsberichte : HIV-Infektion Pädiatrische Hämostaseologie Synovitis Thrombophilie: APC-Cofaktor Hepatitis C. Springer, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
34

Wilson, Deanna. Hepatitis. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199976805.003.0035.

Full text
Abstract:
Hepatitis A (HAV) and E (HEV) viruses are spread via the fecal-oral route. Hepatitis B virus (HBV) exposure is via occupational or recreational activities. Hepatitis D virus (HDV; also spread parentally) can only coinfect or superinfect those with chronic HBV. Hepatitis C (HCV) transmission is predominantly parenteral; the highest risk group is injection drug users. Prodromal-period patients with acute hepatitis present with vague constitutional symptoms when serum transaminases peak, with elevated serum bilirubin and varying levels of hepatic protein synthesis impairment; during the icteric p
APA, Harvard, Vancouver, ISO, and other styles
35

Gordon, Bruce, and Daniel Farb. OSHA Bloodborne Pathogens Manual and CD, Introductory But Comprehensive OSHA (Occupational Safety and Health) Training for the Managers and Employees in ... to AIDS, HIV, Hepatitis B, and Hepatitis C. UniversityOfHealthCare, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
36

Lopes, Eurides, and Jennifer Husson. Solid Organ Transplantation in HIV-Infected Individuals. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190493097.003.0025.

Full text
Abstract:
End-organ disease has become a major cause of morbidity and mortality in HIV-infected patients due to increased life expectancy, increasing the demand for organ transplantation in these patients. The care of HIV-infected transplant recipients warrants a multidisciplinary team approach, including the transplant team, pharmacists, infectious disease specialists, nurses, and patients and their families. The immunosuppression of HIV-infected recipients post-transplant does not appear to further advance HIV disease. The post-transplant risk for HIV-infected recipients of opportunistic infections do
APA, Harvard, Vancouver, ISO, and other styles
37

Farb, Daniel. OSHA Bloodborne Pathogens 5 Users: Introductory but Comprehensive OSHA (Occupational Safety and Health) Training for the Managers and Employees in a Worker ... to AIDS, HIV, Hepatitis B, and Hepatitis C. UniversityOfHealthCare, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
38

Huyghebaert, Trudy. Is the Child-Pugh classification or other factors useful to predict hepatotoxicity following HAART in patients co-infected with HIV and hepatitis C? 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
39

Keshav, Satish, and Palak Trivedi. Viral hepatitis. Edited by Patrick Davey and David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0212.

Full text
Abstract:
Hepatitis means ‘inflammation of the liver’ and is manifest with symptoms that include malaise, anorexia, fever, flu-like symptoms, and pain in the right upper quadrant of the abdomen, with the pain being caused by swelling of the liver and its capsule. Elevations in circulating hepatic enzymes, particularly aspartate transaminase and alanine transaminase, are common, with jaundice occurring some time after the onset of other symptoms and signs. There are five viruses that primarily cause viral hepatitis: hepatitis A, B, C, D, and E viruses, abbreviated HAV, HBV, HCV, HDV, and HEV, respectivel
APA, Harvard, Vancouver, ISO, and other styles
40

Winston, Jonathan, Etti Zeldis, John A. Grimaldi, and Esteban Martínez. HIV-Associated Nephropathy, End-Stage Renal Disease, Dialysis, and Kidney Transplant. Edited by Mary Ann Cohen, Jack M. Gorman, Jeffrey M. Jacobson, Paul Volberding, and Scott Letendre. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199392742.003.0044.

Full text
Abstract:
Antiretroviral therapy has changed the phenotype of HIV-related kidney disease to a more chronic disease model. In addition to HIV-associated nephropathy (HIVAN), patients with HIV may experience kidney dysfunction related to other chronic illnesses, such as diabetes, hypertension, and hepatitis C. Patients with HIV should be monitored for the development of chronic kidney disease and the potential nephrotoxicity of antiretroviral therapy. For patients with HIV who progress to end-stage renal disease, the outcomes on dialysis and management of the dialysis procedure are similar to the outcomes
APA, Harvard, Vancouver, ISO, and other styles
41

Bulterys, Marc, Julia Brotherton, and Ding-Shinn Chen. Prevention of Infection-Related Cancers. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190238667.003.0066.

Full text
Abstract:
This chapter discusses primary prevention measures that disrupt transmission of oncogenic infections. It begins by discussing vaccination against hepatitis B virus (HBV) and human papillomavirus (HPV), two major causes of cancer for which safe and effective vaccines are currently available. It briefly discusses the importance of treatment and prophylaxis against human immunodeficiency virus type 1 (HIV-1), which potentiates the virulence of other viral infections as well as directly increasing the incidence of non-Hodgkin lymphoma. It does not discuss the treatment of HBV or hepatitis C virus
APA, Harvard, Vancouver, ISO, and other styles
42

Beattie, R. Mark, Anil Dhawan, and John W.L. Puntis. Hepatitis C. Oxford University Press, 2011. http://dx.doi.org/10.1093/med/9780198569862.003.0058.

Full text
Abstract:
Epidemiology 424Risk of transmission 424Clinical features 424Specific viral tests 425Diagnosis of HCV infection in infants born to HCV +ve mother 425Management 425• Hepatitis C virus (HCV) is an RNA virus of the flaviviride family.• More than 150 million people are infected with HCV worldwide....
APA, Harvard, Vancouver, ISO, and other styles
43

Fabrizi, Fabrizio. Hepatitis C. Edited by Vivekanand Jha. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199592548.003.0186.

Full text
Abstract:
Hepatitis C virus (HCV) is associated with a large spectrum of histopathological lesions in both native and transplanted kidneys. The exact frequency of kidney damage in HCV-infected patients remains unknown, but the most frequent associated renal lesion is membranoproliferative glomerulonephritis (MPGN) with deposition of immunoglobulin and complement (MPGN type 1), usually in the context of type II mixed cryoglobulinaemia associated with a monoclonal IgM which binds IgG.Various approaches have been tried for the treatment of HCV-related glomerulonephritis, including immunosuppressive therapy
APA, Harvard, Vancouver, ISO, and other styles
44

(Editor), I. Scharrer, and W. Schramm (Editor), eds. 30th Hemophilia Symposium Hamburg 1999: HIV Infection and Epidemiology in Hemophilia; Gene Therapy in Hemophilia A and B; Therapy of Hepatitis C; Inhibitors ... Pediatric Hemostasiology; Case Reports. Springer, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
45

Honegger, Jonathan R. Hepatitis C Virus. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190604813.003.0005.

Full text
Abstract:
An estimated 185 million individuals have been infected with hepatitis C virus (HCV) worldwide. Although often clinically silent for decades, chronic HCV infection predisposes to late-onset complications, including liver cirrhosis and hepatocellular carcinoma. Mother-to-child transmission (MTCT) of HCV affects approximately 5% of children born to viremic mothers and is the primary route of HCV infection in young children. While some vertically acquired HCV infections are resolved during the first years of life, many persist indefinitely. Chronically infected children tend to be asymptomatic an
APA, Harvard, Vancouver, ISO, and other styles
46

Franceschi, Silvia, Hashem B. El-Serag, David Forman, Robert Newton, and Martyn Plummer. Infectious Agents. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190238667.003.0024.

Full text
Abstract:
Eleven infectious agents (seven viruses, three parasites, and one bacterium) have been classified by the International Agency for Research on Cancer as carcinogenic to humans for one or more cancer sites: hepatitis B virus; hepatitis C virus; thirteen types of human papillomavirus (HPV); human immunodeficiency virus type 1 (HIV-1); human T-cell leukemia virus type 1; Epstein-Barr virus; Kaposi sarcoma herpesvirus; Helicobacter pylori; Opisthorchis viverrini; Clonorchis sinensis; and Schistosoma haematobium. Other infectious agents, such as Merkel cell polyomavirus, Plasmodium falciparum, and c
APA, Harvard, Vancouver, ISO, and other styles
47

Russi, Mark. Biological Hazards. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190662677.003.0016.

Full text
Abstract:
This chapter describes various biological hazards and their impact on workers and others. A major focus of the chapter is biological hazards in healthcare and laboratory settings, including exposure to bloodborne pathogens and prevention of diseases related to them. Sections deal with sharps injuries, HIV/AIDS, hepatitis B virus, hepatitis C virus, tuberculosis, and other infectious diseases that can be acquired in the work environment via direct contact, droplet or airborne spread, or fecal-oral transmission. In addition, infectious agents spread by animal contact or arthropod vectors in a br
APA, Harvard, Vancouver, ISO, and other styles
48

Leung, Doris G. Neuropathies Associated with Infection or Toxic Exposure. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199937837.003.0113.

Full text
Abstract:
Among the many causes of peripheral neuropathy are those mediated by environmental exposure to infectious and toxic agents. The most common neuropathy associated with HIV is HIV-associated distal sensory polyneuropathy (HIV-DSP). The clinical presentation of HIV-DSP is one of a distal, symmetric, often painful, small-fiber sensory axonal polyneuropathy. Other infectious causes of neuropathy include hepatitis C, leprosy, Lyme disease, rabies, and diphtheria, and antibiotic drugs such as isoniazid can also cause neuropathy. Heavy metals and a variety of other toxins including chemotherapeutic ag
APA, Harvard, Vancouver, ISO, and other styles
49

Matthews, Philippa C. Infections caused by RNA viruses. Edited by Philippa C. Matthews. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780198737773.003.0009.

Full text
Abstract:
This chapter consists of short notes, diagrams, maps, and tables to summarize RNA viruses that are significant causes of disease in the tropics and subtropics. This includes measles, polio, hepatitis A, C, and E viruses, rabies, arboviruses, and viral haemorrhagic fevers. The chapter also includes sections on important retroviruses, HIV, and human T-lymphotropic virus. For ease of reference, each topic is broken down into sections, including classification, epidemiology, microbiology, pathophysiology, clinical syndromes, diagnosis, treatment, and prevention.
APA, Harvard, Vancouver, ISO, and other styles
50

Fox, Grenville, Nicholas Hoque, and Timothy Watts. Infection. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780198703952.003.0012.

Full text
Abstract:
This chapter provides a problem-oriented approach to investigation and treatment of early and late onset neonatal bacterial infection, including group B streptococcus, meningitis, urine infection, conjunctivitis, umbilical sepsis, osteomyelitis, and septic arthritis. In addition, the prevention and management of congenital infection is covered, including hepatitis B and C, HIV, syphilis, CMV, toxoplasma, rubella, herpes simplex, and chickenpox. Other topics covered are infection control (including MRSA), fungal sepsis, TB, and an overview of immunizations in the first year of life.
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!